Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Evaluation of Truflex™ Flexible Stylet as an intubation guide with the D-blade of C-Mac videolaryngoScope during elective tracheal intubation
ISRCTN ISRCTN57679531
DOI 10.1186/ISRCTN57679531
ClinicalTrials.gov identifier
EudraCT number
Public title Evaluation of Truflex™ Flexible Stylet as an intubation guide with the D-blade of C-Mac videolaryngoScope during elective tracheal intubation
Scientific title Assessment of Truflex™ Flexible Stylet versus conventional rigid Portex™ stylet as an intubation guide with the D-blade of C-Mac videolaryngoScope during elective tracheal intubation
Acronym TruScope
Serial number at source U1111-1139-2029
Study hypothesis Endotracheal intubation with the D-blade of C-Mac videolaryngoscope using Truflex™ Flexible Stylet as an intubation guide is easier than using connventional rigid Portex™ stylet as an intubation guide during elective tracheal intubation.
Lay summary Background and study aims
Patients who are very sick in the intensive care unit (ICU) or those undergoing general anesthesia for surgery require their breathing passage (trachea) to be connected to the ventilator by a tube called the endotracheal tube (ETT). To help locate the glottis, which is the opening of the trachea inside the patient’s mouth, a special device called the videolaryngoscope is used. With the help of this device, the image of the glottis can be visualized from the tip of the videolaryngoscope blade onto a viewing screen outside. Although videolaryngoscopes provide excellent visualization of the glottis, they often pose difficulty in inserting the ETT into the trachea via the glottis. This is mainly due to the fact that the blades of these devices are highly angulated while the natural curvature of the ETT does not match this angulation and hence fails to be directed towards the visualized glottis. To overcome this, a rigid malleable stylet is placed inside the ETT to give it a desired angulated shape matching that of the videolaryngoscope blade. Unfortunately, the curvature of the styleted ETT cannot be tailor-made to suit individual patients (the glottis position may slightly differ from one patient to the next). This often leads to more than one attempt at inserting the ETT into the glottis: during each attempt the styleted ETT is taken out of the patient’s mouth and its curvature increased or decreased. This takes time and may lead to greater chances of injury to the patient’s mouth cavity and increased heart rate and blood pressure.
To avoid the handicap of the rigid stylet, we aim to use a flexible stylet inside the ETT called the TruflexTm which will make it easier to use the tip of the ETT by pressing on a lever near the operator end of the stylet. We think that this combination of videolaryngoscope and TruflexTm will not only help inserting the ETT into the patient’s trachea but will also reduce time and the incidence of injuries and changes in heart rate and blood pressure.

Who can participate?
All patients coming for elective surgical procedures under general anesthesia needing tracheal intubation can participate in this trial after expressing their verbal consent.

What does the study involve?
Participants will be randomly divided into 2 groups. All patients shall be intubated with the aid of same type of stylet within the ETT, either TruflexTm or PortexTm.

What are the possible benefits and risks of participating?
The outcome of this trial shall benefit patients whose tracheas are to be intubated using videolaryngoscope. There are no added risks that can be attributed to the intervention.

Where is the study run from?
The study shall be run at two different centers: Department of Anesthesia & ICU, Khoula Hospital, Muscat, Sultanate of Oman and Department of Medicine, Jawahar Lal Nehru Medical College, Aligarh, India. The lead centre will be the Department of Anesthesia & ICU, Khoula Hospital, Muscat, Sultanate of Oman.

When is the study starting and how long is it expected to run for?
The study shall commence once we get the approval of the Ethical Issues Committee of the hospital. This generally takes 4-6 weeks. We expect to commence data collection from end of March 2013. We expect that the initial study should be completed within 4-6 weeks. However, the larger study is expected to run for about 6-7 months.

Who is funding the study?
The two researchers (Rashid M Khan & Naresh Kaul from Khoula Hospital, Oman) have personally purchased the TruflexTm flexible stylet. The other devices needed for the study are freely available in the operation theatres of both institutions and needs no funding.

Who is the main contact?
Dr. Naresh Kaul, Senior Consultant
nassn@omantel.net.om & drnareshkaul@gmail.com
Ethics approval Ethical issues committee, Khoula Hospital, Muscat, Sultanate of Oman, 2nd March 2013, MOH/KH/EIC/2/2013
Study design Interventional open-label parallel randomized controlled trial
Countries of recruitment India, Oman
Disease/condition/study domain Patients undergoing elective surgical procedure under general anesthesia needing tracheal intubation
Participants - inclusion criteria 1. Patient has been informed of the investigational nature of this study and has given verbal informed consent in accordance with Hospital Ethical Committee guidelines.
2. Males or females ≥ 18 - 60 years of age
3. American Society of Anesthesiologist’s grade I and II patients
4. Elective surgical procedure under general anesthesia needing tracheal intubation
Participants - exclusion criteria 1. Pregnant female
2. Known allergies to either study devices or its components
3. Known bleeding/coagulation disorder
4. Immobilized cervical spine
5. Any pathologies of the mouth, pharynx or larynx
6. Previous ENT surgeries
7. Known malignancies prior to randomisation
8. Chronic kidney disease, chronic liver disease or heart failure
Anticipated start date 15/03/2013
Anticipated end date 15/10/2013
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 154
Interventions Endotracheal Intubation with C-Mac’s D- blade videolaryngoscope by an experienced anesthesiologist using either of the following two intubation guides.

Study Group A: A well lubricated conventional rigid stylet (Portex) will be used to shape the ETT according to the curvature of thevideolaryngoscope blade. This preshaped ETT will be guided into the trachea after obtaining an adequate view of the glottis of an anesthetized and fully relaxed patient using C-Mac’s D- blade videolaryngoscope by an experienced anesthesiologist.

Study Group B. A well lubricated Truflex flexible stylet will be used in place of the rigid stylet to change the curvature of the ETT as per need to negotiate into the glottis of an optimally anesthetized and relaxed patient using C-Mac’s D- blade videolaryngoscope by an experienced anesthesiologist.
Primary outcome measure(s) 1. Successful or failed tracheal intubation
2. Total Intubation Time - This shall include:
2.1. Glotticoscopy time (From introduction of the videolaryngoscope blade between the teeth to the best laryngeal view)
2.2. ETT negotiation time (From receiving the styleted ETT in laryngoscopist’s hand to passage of black line just beyond the vocal cord.
3. Intubation Difficulty Score
Secondary outcome measure(s) 1. Intubation Attempts - maximum 3 attempts, after which the technique will be considered as failure. An attempt shall be counted if the laryngoscope or the ETT needs to be removed for re-oxygenation (drop in oxygen saturation by 5%) or for reshaping of the ETT.
2. Glotticoscopy time & ETT negotiation time as described in primary outcome measure above
3. Overall user satisfaction (Scale 1-10): 1-3=Poor, 4-6=Fair, 7-10=Good)
4. Cormack & Lehanne’s grading
Sources of funding 1. Investigator initiated and funded (Oman)
2. Khoula Hospital (Oman) - Research grants from of the Department of Anesthesia & ICU
Trial website
Publications
Contact name Dr  Naresh  Kaul
  Address Senior Consultant
Department of anesthesia & ICU
Khoula Hospita
Post Box 90
  City/town Muscat
  Zip/Postcode 116
  Country Oman
Sponsor Ministry of Health (Oman)
  Address PO Box 393
  City/town Muscat
  Zip/Postcode 113
  Country Oman
  Sponsor website: http://www.moh.gov.om
Date applied 02/02/2013
Last edited 04/03/2013
Date ISRCTN assigned 12/02/2013
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.